Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neurofeedback for Borderline Personality Disorder

NCT: NCT05398627 · COMPLETED

NCT IDNCT05398627
StatusCOMPLETED
Start Date2022-09-02
Completion2026-04-30

Brief Summary

The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as an intervention for borderline personality disorder.

Frequently Asked Questions

What is Neurofeedback for Borderline Personality Disorder?

Neurofeedback for Borderline Personality Disorder is a clinical trial registered under NCT05398627. Current status: COMPLETED.

What is the status of NCT05398627?

The current status of NCT05398627 (Neurofeedback for Borderline Personality Disorder) is: COMPLETED.

When did Neurofeedback for Borderline Personality Disorder start?

Neurofeedback for Borderline Personality Disorder started on 2022-09-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.